At a glance
ClinicalIndex Comparison RecordN/ACompleted· 179 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Roll-Over Observational Study for the Extended Follow-Up of the Volunteers of the ISS T-003 Trial (ISS T-003 EF-UP2020)
In Brief
An observational study for HIV Infections. Completed, enrolled 179 participants across 1 site.
Detailed Summary
A further extension of the follow-up of the volunteers of the ISS T-003 trial is being conducted in order to evaluate the persistence of vaccine immunogenicity as well as of the immunological and virological effects induced by the therapeutic immunization with Tat after about 10 years from vaccination.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHIV Infections
CountriesSouth Africa
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedJan 2023
Enrollment StartJan 2023
Primary CompletionDec 2023
Study CompletionJun 2024
TodayJul 2026
First PostedJan 11, 2023
Enrollment StartJan 25, 2023
Primary CompletionDec 31, 2023
Study CompletionJun 30, 2024
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 3.5 years ago